Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

625 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response.
Her Z, Teng TS, Tan JJ, Teo TH, Kam YW, Lum FM, Lee WW, Gabriel C, Melchiotti R, Andiappan AK, Lulla V, Lulla A, Win MK, Chow A, Biswas SK, Leo YS, Lecuit M, Merits A, Rénia L, Ng LF. Her Z, et al. Among authors: gabriel c. EMBO Mol Med. 2015 Jan;7(1):24-41. doi: 10.15252/emmm.201404459. EMBO Mol Med. 2015. PMID: 25452586 Free PMC article.
Neutrophils: neglected players in viral diseases.
Gabriel C, Her Z, Ng LF. Gabriel C, et al. DNA Cell Biol. 2013 Dec;32(12):665-75. doi: 10.1089/dna.2013.2211. Epub 2013 Nov 15. DNA Cell Biol. 2013. PMID: 24236425 Review.
Efficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Weisinger J, Bouzid R, Fadlallah J, Barbet C, Provot F, Poullin P, Neel A, Marie M, Rieu V, Kanouni T, Moranne O, Azoulay E, Marjanovic Z, Corre E, Joly AC, Baylatry MT, Joly BS, Veyradier A, Coppo P; French National Center for Thrombotic Microangiopathies (CNR‐MAT). Weisinger J, et al. Am J Hematol. 2024 Dec 12. doi: 10.1002/ajh.27550. Online ahead of print. Am J Hematol. 2024. PMID: 39668454 No abstract available.
A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver.
Perry AS, Hadad N, Chatterjee E, Jimenez-Ramos M, Farber-Eger E, Roshani R, Stolze LK, Betti MJ, Zhao S, Huang S, Martens L, Kendall TJ, Thone T, Amancherla K, Bailin S, Gabriel CL, Koethe J, Carr JJ, Terry JG, Vaitinadin NS, Freedman JE, Tanriverdi K, Alsop E, Van Keuren-Jensen K, Sauld JFK, Mahajan G, Khan SS, Colangelo L, Nayor M, Fisher-Hoch S, McCormick JB, North KE, Below JE, Wells QS, Abel ED, Kalhan R, Scott C, Guilliams M, Gamazon ER, Fallowfield JA, Banovich NE, Das S, Shah R. Perry AS, et al. Among authors: gabriel cl. Cell Rep Med. 2024 Dec 17;5(12):101871. doi: 10.1016/j.xcrm.2024.101871. Epub 2024 Dec 9. Cell Rep Med. 2024. PMID: 39657669 Free article.
Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial.
Dark P, Hossain A, McAuley DF, Brealey D, Carlson G, Clayton JC, Felton TW, Ghuman BK, Gordon AC, Hellyer TP, Lone NI, Manazar U, Richards G, McCullagh IJ, McMullan R, McNamee JJ, McNeil HC, Mouncey PR, Naisbitt MJ, Parker RJ, Poole RL, Rostron AJ, Singer M, Stevenson MD, Walsh TS, Welters ID, Whitehouse T, Whiteley S, Wilson P, Young KK, Perkins GD, Lall R; ADAPT-Sepsis Collaborators. Dark P, et al. JAMA. 2024 Dec 9. doi: 10.1001/jama.2024.26458. Online ahead of print. JAMA. 2024. PMID: 39652885
625 results